Evidence map›Paper›PMID 42624072›Full record

ArticleJournal of acquired immune deficiency syndromes (1999)2026

Association of under-reporting of alcohol use with HIV viral non-suppression and an all-cause mortality risk score among people with HIV on antiretroviral therapy.

Cristina Espinosa da Silva, Robin Fatchm, Nneka Emenyonu, Aaron Scheffler, Winnie R Muyindike, Julian Adong, Evgeny Krupitsky, Elena Blokhina, Kaku So-Armah, Brian Beesiga and 7 more

Abstract read
In one paragraph

Article in Journal of acquired immune deficiency syndromes (1999), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Cristina Espinosa da SilvaDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA; Cristina.EspinosadaSilva@ucsf.edu.ORCID 0000-0003-1684-1616
Robin FatchmDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA; Robin.Fatch@ucsf.edu.
Nneka EmenyonuDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA; Nneka.Emenyonu@ucsf.edu.
Aaron SchefflerDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Aaron.Scheffler@ucsf.edu.
Winnie R MuyindikeDepartment of Medicine, Mbarara University of Science and Technology; Mbarara Regional Referral Hospital, Mbarara, Uganda; wmuyindike@gmail.com.
Julian AdongDepartment of Medicine, Mbarara University of Science and Technology, Mbarara, Uganda; adongjulian@gmail.com.
Evgeny KrupitskyV.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, Bekhtereva St. Petersburg, Russia; kruenator@gmail.com.
Elena BlokhinaPavlov University, St. Petersburg, Russia; blokhinaelena@gmail.com.
Kaku So-ArmahBoston University, MA, USA; kaku@bu.edu.
Brian BeesigaInfectious Diseases Research Collaboration, Kampala, Uganda; beesigab@gmail.com.
Kara MarsonUniversity of California San Francisco, San Francisco, CA, USA; Kara.Marson@ucsf.edu.
Frank J PalellaFeinberg School of Medicine, Northwestern University, Chicago, IL, USA, f-palella@northwestern.edu.
Gabriel ChamieDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA; Gabriel.Chamie@ucsf.edu.
Isabel E AllenDepartment of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, CA, USA; Isabel.Allen@ucsf.edu.
Phyllis C TienDepartment of Medicine, University of California San Francisco, CA, USA; Phyllis.Tien@ucsf.edu.
Judith A HahnDepartment of Medicine, University of California San Francisco, San Francisco, CA, USA; Judy.Hahn@ucsf.edu.
Multicenter AIDS Cohort Study (MACS) / Women’s Interagency HIV Study (WIHS) Combined Cohort Study (MWCCS), the Russia Alcohol Research Collaboration on HIV/AIDS (Russia ARCH I), the Studying Partial agonists for Ethanol and Tobacco Elimination in Russians with HIV (ST PETER HIV) RCT, the Alcohol Drinkers’ Exposure to Preventive Therapy for TB (ADEPT-T) Study, the Mobile Technology to Extend Clinic-Based Counseling for HIV+s in Uganda (Extend) RCT, the Drinkers’ Intervention to Prevent Tuberculosis (DIPT) RCT, and International URBAN Alcohol Research Collaboration on HIV/AIDS Center

Funding

UCLA Clinical Translational Science InstituteUL1TR001881 · NCATS · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI ARLEEN F. BROWN, ARASH NAEIM · 2016 to 2026
$118.1M
Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Renee A. Heffron · 1988 to 2026
$84.1M
Engaging University of California Stakeholders for Biorespository ResearchUL1TR000004 · NCATS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI GRANDIS, JENNIFER RUBIN · 2012 to 2015
$78.0M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Virology and Molecular Biomarkers CoreP30AI050409 · NIAID · EMORY UNIVERSITY · PI Ann M Chahroudi, Colleen F Kelley · 2002 to 2026
$74.0M
QAQC Johns Hopkins Institute for Clinical and Translational ResearchUL1TR003098 · NCATS · JOHNS HOPKINS UNIVERSITY · PI FORD, DANIEL ERNEST · 2019 to 2023
$57.7M
Maternal Morbidity and Mortality: Risk Factors, Early Detection and Personalized InterventionUL1TR001409 · NCATS · GEORGETOWN UNIVERSITY · PI GONDRE-LEWIS, MARJORIE C, MELLMAN, THOMAS A · 2015 to 2024
$37.8M
SF Bay Area MACS/WIHS Combined Cohort StudyU01HL146242 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Bradley E Aouizerat, Jennifer Cohen Price · 2019 to 2026
$36.3M
Sex differences in the role of multi-omicsin HIV-associated carotid artery atherosclerosisU01HL146193 · NHLBI · JOHNS HOPKINS UNIVERSITY · PI Stephen J Gange, Elizabeth Topper · 2019 to 2026
$35.8M
University of Miami Developmental Center for AIDS Research (D-CFAR)P30AI073961 · NIAID · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI Savita Pahwa · 2007 to 2026
$33.8M
Patient and Population Health Outcomes Research SWGP30AI124414 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI Vinayaka R. Prasad · 2017 to 2026
$28.3M
Institutional Career Development CoreKL2TR001432 · NCATS · GEORGETOWN UNIVERSITY · PI UMANS, JASON G · 2015 to 2024
$7.5M
NCATS NIH HHS KL2 TR001432NCATS NIH HHS TL1 TR001431NCATS NIH HHS UL1 TR000004NCATS NIH HHS UL1 TR001409NCATS NIH HHS UL1 TR001881NCATS NIH HHS UL1 TR003098NHLBI NIH HHS U01 HL146193NHLBI NIH HHS U01 HL146242NIAAA NIH HHS K24 AA022586NIAAA NIH HHS R01 AA024990NIAAA NIH HHS R01 AA029962NIAAA NIH HHS U01 AA020776NIAAA NIH HHS U01 AA020780NIAAA NIH HHS U01 AA021989NIAAA NIH HHS U01 AA026221NIAAA NIH HHS U01 AA026223NIAAA NIH HHS UH2 AA026226NIAID NIH HHS P30 AI027767NIAID NIH HHS P30 AI050409NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI073961NIAID NIH HHS P30 AI124414NIMH NIH HHS P30 MH116867
6 · The paper itself

Abstract

backgroundUnhealthy alcohol use contributes to poor HIV-related outcomes. Alcohol under-reporting may be associated with HIV viral non-suppression and all-cause mortality risk, especially at the high end of the spectrum. We evaluated whether alcohol under-reporting was associated with these outcomes among PWH with unhealthy alcohol use who were receiving ART.

methodsWe pooled data from six studies of PWH in Uganda (ADEPT-T, DIPT, Extend), United States (MWCCS), and Russia (Russia ARCH 1, St Peter). We included PWH on ART who engaged in unhealthy drinking as determined by the alcohol biomarker phosphatidylethanol (PEth)≥50ng/mL. Self-reported alcohol use was assessed using the Alcohol Use Disorders Identification Test-Consumption (AUDIT-C). We defined under-reporting of high-risk alcohol use as PEth≥200ng/mL and AUDIT-C score<6, and examined HIV viral non-suppression (≥200copies/mL or limit of assay detection) and an all-cause mortality risk score (Veterans Aging Cohort Study [VACS] Index 1.0) as outcomes. We explored level of -under-reporting of alcohol use using a continuous variable.

resultsIn our sample of 1,435 PWH with unhealthy drinking, 24% under-reported high-risk alcohol use (prevalence range 1-34% across studies). We observed positive, non-significant associations between under-reporting of high-risk alcohol use and viral non-suppression and all-cause mortality risk score. An exploratory continuous under-reporting variable was significantly positively associated with all-cause mortality risk.

conclusionsOur findings indicate that under-reporting of high-risk alcohol use is common among PWH and suggest that under-reporting of alcohol use may mask other health issues, as reflected by increased mortality index scores. Low-cost methods to improve alcohol use are needed.

Identifiers

PMID42624072
PMCPMC13520564

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.